To resolve on the 2023 financial statements, including the management report, the individual and consolidated accounts, the corporate governance report (that includes the report on remuneration), non-financial information, including sustainability, and other corporate, supervisory and audit information documents, which form the Integrated Report.



To resolve on the profit allocation proposal for the 2023 financial year.

Item Three:

To generally appraise the Company's management and supervision.



To deliberate on the election of the Statutory Auditor and Alternate for the 2024/2026 term of office.



To deliberate on the approval of the remuneration policy of the members of the Company’s management and supervisory bodies, including a plan for assigning CTT share options to the Executive Directors.



To resolve on the granting of authorisation to the Board of Directors for the acquisition and disposal of own shares by the Company and its subsidiaries.

Item Seven:

To deliberate on the reduction of the share capital by up to 3,825,000.00 EUR for the purpose of releasing excess capital, by means of the cancellation of up to 7,650,000 shares representing up to 5.3% of the share capital already acquired or to be acquired under the share buyback programme, as well as related reserves, and with the consequent amendment of paragraphs 1 and 2 of Article 4 of the Articles of Association.